Document is current

Article History

Received: 21 July 2025

Accepted: 4 September 2025

First Online: 14 October 2025

Declarations

:

: Brett King has served on advisory boards and/or is a consultant and/or is a clinical trial investigator and/or is on a data monitoring committee for AbbVie, AltruBio Inc, Almirall, Amgen, AnaptysBio, Apogee Therapeutics, Aquestive, Arena Pharmaceuticals, Aslan Pharmaceuticals, Bristol Meyers Squibb, Concert Pharmaceuticals Inc, Equillium, GSK, Horizon Therapeutics, Eli Lilly and Company, Incyte Corp, Janssen Pharmaceuticals, LEO Pharma, Merck, Otsuka/Visterra Inc, Pfizer Inc, Q32 Bio Inc, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, Takeda, TWi Biotechnology Inc, and Ventyx Biosciences Inc. He has served on speakers bureaus for AbbVie, Incyte, Eli Lilly, Pfizer, Regeneron, and Sanofi Genzyme. Amy McMichael has served on advisory boards and/or is a consultant and/or is a clinical trial investigator for Arcutis, Almirall, AbbVie, Bristol Meyers Squibb, Concert, Eli Lilly, Galderma, Incyte, Janssen, Johnson & Johnson, Kenvue, L’Oreal, Leo, Pelage, Pfizer, Procter & Gamble, Revian, Sanofi Regeneron, Sun Pharma, and UCB. Rodney Sinclair has provided professional services to Aerotech, AbbVie, AstraZeneca, Akesobio, Amgen, Arcutis, Arena, Ascend, Bayer, BMS, Boehringer Ingelheim, Celgene, Coherus BioSciences, Connect, Cutanea, Demira, Eli Lilly, Galderma, GSK, Janssen, LEO Pharma, MedImmune, Merck, MSD, Novartis, Oncobiologics, Pfizer, Regeneron, Reistone, Roche, Samson Clinical, Sanofi, Sun Pharma, and UCB. Sergio Vañó-Galvan reports consulting fees and payment/honoraria from Pfizer and Eli Lilly. Robert Wolk, Deborah Woodworth, Koshika Soma, Feriel Robbana, Alexandre Lejeune, Lynne Napatalung, Ernest Law, Dalia Wajsbrot, Cunshan Wang, and Satrajit Roychoudhury are employees of and own stock in Pfizer Inc.

: This study will be conducted in accordance with the protocol and with the consensus ethical principles derived from international guidelines, including the Declaration of Helsinki and CIOMS International Ethical Guidelines; applicable International Council for Harmonisation Good Clinical Practice guidelines; and applicable regional laws and regulations, including privacy laws. The protocol, protocol amendments, and other relevant documents are reviewed and approved by the sponsor and submitted by the investigator for review and approval by the institutional review board/ethics committee before the study can be initiated. All participants or their legally authorized representative must provide written informed consent.